[Arrhythmia risk stratification based on etiological and anatomo-structural factors]

Area of Science:

• Cardiology
• Heart Failure Research
• Sudden Cardiac Death

Background:

• Sudden death is a frequent complication in heart failure patients, particularly in NYHA functional classes II and III.
• The underlying cause of heart failure (ischemic vs. non-ischemic) dictates the primary mechanisms of sudden death.

Purpose of the Study:

• To elucidate the distinct mechanisms and risk stratification differences in sudden death between ischemic and non-ischemic heart failure.
• To highlight the implications of these differences on diagnostic and therapeutic approaches.

Main Methods:

• Review of mechanisms of sudden death in ischemic heart disease (arrhythmic, bradyarrhythmic) and non-ischemic heart disease (arrhythmic, electromechanical dissociation, embolism).
• Comparison of risk stratification reliability of non-invasive studies and programmed ventricular stimulation in ischemic versus non-ischemic heart failure.
• Analysis of therapeutic implications, including implantable defibrillator use in primary prevention.

Main Results:

• Arrhythmic sudden death (ventricular tachycardia/fibrillation) is predominant in ischemic heart failure.
• Non-ischemic heart failure exhibits a lower percentage of arrhythmic sudden deaths, with contributions from electromechanical dissociation and embolism.
• Risk stratification tools and therapeutic strategies, such as implantable defibrillators, show differential reliability and application based on the etiology of heart failure.

Conclusions:

• The etiology of heart failure significantly influences the mechanisms, risk stratification, and treatment of sudden death.
• Current diagnostic and therapeutic strategies for sudden death prevention are largely based on studies in ischemic heart disease patients and require adaptation for non-ischemic cases.